drugset / Trial / NCT01807624
Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
Phase 2
Completed
24 enrolled
St. Renatus, LLC
Analytical Bio-Chemistry Laboratories, Inc. · collabRho, Inc. · collabTriligent International · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline with blood draws over 24 hours.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxymetazoline | Other / unclassified | 0.3 mg | Intranasal |
| Subject | tetracaine | Other / unclassified | 18 mg | Intranasal |
Indications
No indication recorded.